Behavioral antecedents of firm's ego-network competitiveness: The case of the global pharmaceuticals

Intra-industry alliance networks provide a firm with both collaborative opportunities and competitive challenges. When forming alliance networks within a particular industry, firms need to consider to which extent they compete in the same markets with their alliance network partners, who are also th...

Descripción completa

Detalles Bibliográficos
Autores: Shijaku, Elio, Ritala, Paavo
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/212929
Acceso en línea:https://hdl.handle.net/2445/212929
Access Level:acceso abierto
Palabra clave:Aliances estratègiques (Empreses)
Indústria farmacèutica
Strategic alliances (Business)
Pharmaceutical industry
id ES_39ca94b52a5bb61c044d05272e3442ea
oai_identifier_str oai:diposit.ub.edu:2445/212929
network_acronym_str ES
network_name_str España
repository_id_str
spelling Behavioral antecedents of firm's ego-network competitiveness: The case of the global pharmaceuticalsShijaku, ElioRitala, PaavoAliances estratègiques (Empreses)Indústria farmacèuticaStrategic alliances (Business)Pharmaceutical industryIntra-industry alliance networks provide a firm with both collaborative opportunities and competitive challenges. When forming alliance networks within a particular industry, firms need to consider to which extent they compete in the same markets with their alliance network partners, who are also their industry peers. However, previous literature has not exhaustively addressed the antecedents of a firm's competitive behavior with their alliance network peers – i.e., a phenomenon we label ego-network competitiveness. This study draws on extensive panel data from the top global pharmaceuticals to examine this question. Combining behavioral and network perspectives, we test two competing hypotheses on how ego-network competitiveness varies relative to performance feedback and whether structural prominence moderates this relationship. Our results show that performance above and below aspirations increases ego-network competitiveness through high-intensity responses (i.e., problemistic and slack search). We also find that performance above aspirations increases ego-network competitiveness for firms with high structural prominence.Elsevier2023info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/212929Articles publicats en revistes (Empresa)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: https://doi.org/10.1016/j.lrp.2023.102308Long Range Planning, 2023, vol. 56, num.3https://doi.org/10.1016/j.lrp.2023.102308cc-by-nc-nd (c) Shijaku et al., 2023http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/2129292026-05-27T06:46:51Z
dc.title.none.fl_str_mv Behavioral antecedents of firm's ego-network competitiveness: The case of the global pharmaceuticals
title Behavioral antecedents of firm's ego-network competitiveness: The case of the global pharmaceuticals
spellingShingle Behavioral antecedents of firm's ego-network competitiveness: The case of the global pharmaceuticals
Shijaku, Elio
Aliances estratègiques (Empreses)
Indústria farmacèutica
Strategic alliances (Business)
Pharmaceutical industry
title_short Behavioral antecedents of firm's ego-network competitiveness: The case of the global pharmaceuticals
title_full Behavioral antecedents of firm's ego-network competitiveness: The case of the global pharmaceuticals
title_fullStr Behavioral antecedents of firm's ego-network competitiveness: The case of the global pharmaceuticals
title_full_unstemmed Behavioral antecedents of firm's ego-network competitiveness: The case of the global pharmaceuticals
title_sort Behavioral antecedents of firm's ego-network competitiveness: The case of the global pharmaceuticals
dc.creator.none.fl_str_mv Shijaku, Elio
Ritala, Paavo
author Shijaku, Elio
author_facet Shijaku, Elio
Ritala, Paavo
author_role author
author2 Ritala, Paavo
author2_role author
dc.subject.none.fl_str_mv Aliances estratègiques (Empreses)
Indústria farmacèutica
Strategic alliances (Business)
Pharmaceutical industry
topic Aliances estratègiques (Empreses)
Indústria farmacèutica
Strategic alliances (Business)
Pharmaceutical industry
description Intra-industry alliance networks provide a firm with both collaborative opportunities and competitive challenges. When forming alliance networks within a particular industry, firms need to consider to which extent they compete in the same markets with their alliance network partners, who are also their industry peers. However, previous literature has not exhaustively addressed the antecedents of a firm's competitive behavior with their alliance network peers – i.e., a phenomenon we label ego-network competitiveness. This study draws on extensive panel data from the top global pharmaceuticals to examine this question. Combining behavioral and network perspectives, we test two competing hypotheses on how ego-network competitiveness varies relative to performance feedback and whether structural prominence moderates this relationship. Our results show that performance above and below aspirations increases ego-network competitiveness through high-intensity responses (i.e., problemistic and slack search). We also find that performance above aspirations increases ego-network competitiveness for firms with high structural prominence.
publishDate 2023
dc.date.none.fl_str_mv 2023
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/212929
url https://hdl.handle.net/2445/212929
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.1016/j.lrp.2023.102308
Long Range Planning, 2023, vol. 56, num.3
https://doi.org/10.1016/j.lrp.2023.102308
dc.rights.none.fl_str_mv cc-by-nc-nd (c) Shijaku et al., 2023
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by-nc-nd (c) Shijaku et al., 2023
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv Articles publicats en revistes (Empresa)
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869406193242341376
score 15.812455